Reduced monomeric CD4 is the preferred receptor for HIV
journal contributionposted on 2023-05-19, 16:16 authored by Matthias, LJ, Iman AzimiIman Azimi, Tabrett, CA, Hogg, PJ
CD4 is a co-receptor for binding of T cells to antigen-presenting cells and the primary receptor for the human immunodeficiency virus type 1 (HIV). CD4 exists in three different forms on the cell surface defined by the state of the domain 2 cysteine residues: an oxidized monomer, a reduced monomer, and a covalent dimer linked through the domain 2 cysteines. The disulfide-linked dimer is the preferred immune co-receptor. The form of CD4 that is preferred by HIV was examined in this study. HIV entry and envelope-mediated cell-cell fusion were tested using cells expressing comparable levels of wild-type or disulfide bond mutant CD4 in which the domain 2 cysteines were mutated to alanine. Eliminating the domain 2 disulfide bond increased entry of HIV reporter viruses and enhanced HIV envelope-mediated cell-cell fusion 2-4-fold. These observations suggest that HIV enters susceptible cells preferably through monomeric reduced CD4, whereas dimeric CD4 is the preferred receptor for binding to antigen-presenting cells. Cleavage of the domain 2 disulfide bond is possibly involved in the conformational change in CD4 associated with fusion of the HIV and cell membranes.
Publication titleJournal of Biological Chemistry
Department/SchoolSchool of Pharmacy and Pharmacology
PublisherAmer Soc Biochemistry Molecular Biology Inc
Place of publicationUnited States
Rights statementThis research was originally published in the Journal of Biological Chemistry. Lisa J. Matthias, Iman Azimi, Catherine A. Tabrett and Philp J. Hogg. Reduced monomeric CD4 is the preferred receptor for HIV. J. Biol. Chem. 2010; 285:p40793-40799. © the American Society for Biochemistry and Molecular Biology